article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

article thumbnail

Omnicell Unveils Groundbreaking Robotic Compounding Technology in Winter 2022 Release

Omnicell

Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. A new era of IV robotics in the IVX Station , new technology introduced as part of Omnicell's Winter 2022 Release.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reducing Drug Spend with IV Robotic Services

Omnicell

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.

article thumbnail

Advocates for Safe IV Preparation Practices Share Their Inspiration Podcast

Omnicell

In fact, in a 2020 ISMP Sterile Compounding Pulse Check conducted with 634 pharmacy practitioners, only 25% of respondents report using technologies that include barcode verification, images, and gravimetric verification for 50% of compounded sterile products. .